A Novel Treatment for Metastatic Prostate Cancer

Search text
Active Filters
Carlos Camacho
About 1 result
(0.09 seconds)
B signaling pathway and responses of the same cell types to a library of bioactive compounds.
From the 717 initial hit compounds, docking studies were carried out in silico on key targets in the TNF receptor identifying three compounds of interest.
From the 717 initial hit compounds, docking studies were carried out in silico on key targets in the TNF receptor identifying three compounds of interest.
    • Technology Type
      • 1
        Therapeutic Modality
      • Add ...
    • Technology Subtype
      • 1
        Small Molecule
      • Add ...
    • Therapeutic Areas
      • 1
        Immunology
      • Add ...
    • Therapeutic Indications
      • Add ...
    • Tags
      • 1
        Autoimmune
      • Add ...
    • Lead Inventor
      • 2
        Kazunori Koide
      • 2
        Thomas Smithgall
      • 2
        Xiaosong Wang
      • 1
        Alexander Deiters
      • 1
        Alexander Doemling
      • 1
        Carlos Camacho
      • Add ...
    • Department
      • 1
        Med-Computational and Systems Biology
      • Add ...
    • All Tech Innovators
      • 1
        Carlos Jaime Camacho
      • 1
        Robin E C Lee
      • Add ...
    • Date Submitted
This site uses cookies to deliver a better user experience. Learn more.